Clinical Trial Update: Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing intermittent versus continuous HAART for adults with chronic HIV infection in Uganda has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV | Phase 3 | Status: COMPLETED